Allscripts Healthcare Solutions, Inc. - common stock (MDRX) Social Stream
Allscripts Healthcare Solutions Inc (MDRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MDRX.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 11 | $22 | $16 | $18.777 | $18.26 | 2.83% |
| 11 | $22 | $16 | $18.555 | $18.26 | 1.62% |
| 12 | $22 | $16 | $18.3 | $18.26 | 0.22% |
The Trend in the Analyst Price Target
Over the past 19 months, MDRX's average price target has gone up $10.71.
Over the past 19 months, MDRX's average upside potential has been -0.19%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-14 | 11 | 22 | 16 | 18.777 | 17.63 | 6.51% |
| 2020-05-29 | 22 | 12 | 6 | 8.070 | NA | NA% |
MDRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.45 | 3 | 2 | 5 | 1 | 1 | 11 |
The Trend in the Broker Recommendations
Over the past 21 months, MDRX's average broker recommendation rating worsened by 0.02.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MDRX has a higher upside potential (average analyst target price relative to current price) than 45.54% of all US stocks.
- MDRX has a higher number of analysts covering the stock than 262.09% of stocks in the mid market cap category.
- MDRX has a higher average analyst price target than 55.03% of stocks in the mid market cap category.
- The variance in analysts' estimates of MDRX is less than -7.15000000000001% of Technology stocks.
Stocks similar to Allscripts Healthcare Solutions Inc in the Computers industry regarding analyst recommendations and price targets are MNDT, JNPR and FFIV.
Make investment decisions regarding MDRX using the data that counts. Try POWR Ratings for free.